REGISTERED
on 01 Aug 2023
Last Applicant/ Owned by
N-5009 Bergen
NO
Serial Number
79330538 filed on 22nd Oct 2021
Registration Number
7123344 registered on 01st Aug 2023
Correspondent Address
James M. Theo
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
BERGENBIO
Drug discovery and pharmaceutical drug development services; scientific research services; research and development services in the fields of oncology and immunology; scientific research services related to the role of axl and related kinase signalling in disease; scientific research services related to axl biology and its role in mediating aggressive disease; scientific research services related Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Drug discovery and pharmaceutical drug development services; scientific research services; research and development services in the fields of oncology and immunology; scientific research services related to the role of axl and related kinase signalling in disease; scientific research services related to axl biology and its role in mediating aggressive disease; scientific research services related to biomarker discovery; scientific research services related to the development of diagnostic products and services, in the field of treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; scientific research services related to improving the efficacy of chemotherapy, targeted cancer therapy and immunooncology drugs; research and development services in the field of antibodies, small molecules and proteins; conducting and providing research and development services for others in the field of antibody and small molecule technology; medical and biotechnology research services; research, development and engineering of antibodies, small molecules and proteins, namely, anti-axl antibodies, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins; laboratory research services relating to the production of antibodies, small molecules and proteins, namely, anti-axl antibodies, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins; researching and developing the use of antibodies, small molecules and proteins for the treatment of patients; information, consultancy and advisory services related to the aforesaid services
Class [005]
Pharmaceutical Products
Drugs and pharmaceutical products for medical purposes, namely, medications for the treatment of cancer and severe respiratory infections; drugs and pharmaceutical products for medical purposes incorporating antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors, or selective inhibitors of cell surface proteins, namely, medications for the treatment of cancer and severe respiratory infections; drugs and pharmaceutical products for medical purposes, for use in oncology and for the treatment of cancers, lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for medical purposes; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for medical laboratory analysis; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease testing, namely, the testing for lung cancer, leukaemia, aggressive cancers, immune evasive cancers, metastatic cancers and severe respiratory infections; antibodies, small molecules and proteins for medical purposes; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for medical purposes; protein synthesis inhibitors for medical purposes
Class [001]
Chemical Products
Chemical preparations, chemical compounds, biochemical preparations and biologic compounds for scientific or industrial purposes, or for use in laboratories or in research; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for analytical and diagnostic purposes in laboratory use; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for the experimental production of drugs, pharmaceutical products and biotechnological preparations; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; chemical preparations, chemical compounds, biochemical preparations and biologic compounds for use in the development and manufacture of drugs and pharmaceutical products, namely, drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; active chemical and biochemical ingredients and components for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, for the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; antibodies, small molecules and proteins for scientific or industrial purposes, or for use in laboratories or in research; antibodies, small molecules and proteins for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, for the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; antibodies, small molecules and proteins for use in the development and manufacture of drugs and pharmaceutical products, namely, drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for scientific or industrial purposes, or for use in laboratories or in research; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for use in the development and manufacture of diagnostic products and services, drugs and pharmaceutical products, namely, for the diagnosis and treatment of cancers, including lung cancer, leukaemia, aggressive cancers, immune evasive cancers and metastatic cancers; antibodies, anti-axl antibodies, small molecules, small molecules that inhibit axl kinase, selective inhibitors, selective axl inhibitors, selective axl kinase inhibitors and selective inhibitors of cell surface proteins for use in the development and manufacture of drugs and pharmaceutical products, namely, drugs and pharmaceutical products that target axl, akt3 or other genes, proteins, kinases and enzymes; proteins for use in kinase inhibiting technology, for scientific purposes
Mark Details
Serial Number
No 79330538
Mark Type
No Service Mark
Attorney Docket Number
No TBD
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.01.09 -
Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.15.02 -
Plain single or multiple line polygons
Description of Design Search
The mark consists of the stylized wording "BERGENBIO" to the right of a design of 6 shaded circles and one outlined hexagon arranged in an overall hexagonal shape.
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Nov 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 01st Nov 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 01st Nov 2023 | FINAL DISPOSITION PROCESSED |
| 01st Nov 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 01st Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
| 01st Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 25th Jun 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 07th Jun 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 07th Jun 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 17th May 2023 | NOTIFICATION PROCESSED BY IB |